Methyleugenol protects against t-BHP-triggered oxidative injury by induction of Nrf2 dependent on AMPK/GSK3β and ERK activation

J Pharmacol Sci. 2017 Oct;135(2):55-63. doi: 10.1016/j.jphs.2017.09.003. Epub 2017 Sep 19.

Abstract

Methyleugenol (Mlg), a natural ingredient of many herbs and used as a flavoring substance in dietary products, inhibits inflammation and oxidative stress. The aim of the study is to explore the antioxidative potential of Mlg against tert-butyl hydroperoxide (t-BHP)-triggered oxidative injury and the involvement of antioxidative mechanisms. Our findings indicated that Mlg exposure significantly alleviated t-BHP-stimulated cytotoxicity, suppressed reactive oxygen species (ROS) generation, and increased superoxide dismutase (SOD) and glutathione (GSH) levels, which were related to the induction of the glutamate-cysteine ligase catalytic/modifier (GCLC/GCLM) subunit, heme oxygenase-1 (HO-1), and NAD (P) H: quinone oxidoreductase (NQO1) largely dependent upon upregulating the nuclear factor-erythroid 2-related factor 2 (Nrf2) induction, inhibiting the Keap1 protein expression, and heightening the antioxidant response element (ARE) activity. Additionally, Mlg exposure obviously induced AMP-activated protein kinase (AMPK), glycogen synthase kinase 3β (GSK3β) and extracellular signal-regulated kinase (ERK) phosphorylation, but AMPK and ERK inhibitors treatment exhibited effectively reduced levels of Mlg-enhanced Nrf2 nuclear translocation, respectively. Furthermore, Mlg exposure significantly lessened t-BHP-induced cytotoxicity and ROS production which were evidently abolished by treatment with AMPK and ERK inhibitors and Nrf2 siRNA. Accordingly, Mlg might exhibit a protective role against t-BHP-triggered cytotoxicity via the activation of the AMPK/GSK3β- and ERK-Nrf2 signaling pathways.

Keywords: Methyleugenol; Nrf2; Oxidative stress; Reactive oxygen species.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Animals
  • Anti-Inflammatory Agents*
  • Antioxidants*
  • Cell Survival / drug effects*
  • Cytoprotection*
  • Eugenol / analogs & derivatives*
  • Eugenol / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Glutathione / metabolism
  • Glycogen Synthase Kinase 3 beta / metabolism*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Mice
  • NF-E2-Related Factor 2 / metabolism*
  • Oxidative Stress / drug effects*
  • Oxidative Stress / genetics*
  • Protective Agents / pharmacology*
  • RAW 264.7 Cells
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase / metabolism
  • Up-Regulation / drug effects*
  • tert-Butylhydroperoxide / toxicity*

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Protective Agents
  • Reactive Oxygen Species
  • methyleugenol
  • Eugenol
  • tert-Butylhydroperoxide
  • Superoxide Dismutase
  • Glycogen Synthase Kinase 3 beta
  • Extracellular Signal-Regulated MAP Kinases
  • AMP-Activated Protein Kinases
  • Glutathione